LVTX is a pharmaceutical company focused on biologicals for advanced prostate carcinoma.
It recently secured a collaboration agreement with Merck to assist in the clinical trials and
the financial burdens it imposes in a quid pro quo related to a share of product margins in the
future. On the 15-minute chart, LVTX burst out of a long-standing consolidation...
Symbol: NASDAQ:CTXR
Indicators
Lag RSI
My Opinion: Bullish
Comments: Just added to the watchlist on our site! Check out which other we've already added.
